Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Preterm birth risk quickly and accurately detected with proteomic profiling

03.02.2006


By profiling specific proteins in amniotic fluid for inflammation, researchers at Yale School of Medicine can quickly and accurately detect potentially dangerous infections in pregnant women, and also predict the possibility of premature birth.



The work will be presented at the 26th Annual Society for Maternal-Fetal Medicine (SMFM) meeting on February 2 by Catalin S. Buhimschi, M.D., assistant professor in the Department of Obstetrics, Gynecology & Reproductive Sciences. Buhimschi and his team will receive a March of Dimes Award for Best Research in Prematurity.

"This is one of the first tests of a proteomic profile in a prospective-blind fashion," said Buhimschi. "One of the key advances in this research is that the test was done using fresh samples of amniotic fluid and not using banked amniotic fluid. This is a multidisciplinary approach that combines the basic science with clinical neonatology."


Mass Restricted (MR) score is a specific proteomic profile used in the study. Presence of the biomarkers indicating inflammation in amniotic fluid can be established in 20 to 30 minutes. This test is much faster than the current method of testing microbiological cultures. If no biomarkers are present, then the pregnancy is uncomplicated.

Buhimschi and his team studied 164 fresh samples of amniotic fluid from 131 patients recruited consecutively with symptoms of premature labor. Proteins in a small sample of amniotic fluid were tested to find a link between the amniotic fluid glucose value, white blood cell count and the outcome of the fetus. An MR sore of three or four is highly predictive of adverse pregnancy outcome.

"We can now detect infections at a much more incipient stage with this proteomic profile," said Buhimschi. "The presence of two biomarkers for inflammation indicates the median time for delivery is four days. If all the biomarkers for inflammation are present, delivery time occurs within hours. Studies to test treatment were not possible before. We now have to take it into the clinic and use the results of this test to provide a rapid treatment to the mother and its baby. This platform is also available to help diagnose other diseases."

In addition to this abstract, Yale University has the most presentations at SMFM supported using funds obtained via extramural NIH mechanisms.

Karen N. Peart | EurekAlert!
Further information:
http://www.yale.edu

More articles from Health and Medicine:

nachricht Collagen nanofibrils in mammalian tissues get stronger with exercise
14.12.2018 | University of Illinois College of Engineering

nachricht New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>